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genus Streptomyces generally occurs in the stationary phase in liquid medium, and correlates temporally with the onset of morphological differentiation in surfacegrown cultures (Demain et al., 1983; Chater, 1989) . Much progress has been made in elucidating the organization of antibiotic biosynthetic gene clusters in several different
Streptomyces species (Hunter and Baumberg, 1989) , and a number of pathway-specific regulatory genes have been identified that are required for the activation of their cognate biosynthetic structural genes (Distler et al., 1987; Narva and Feitelson, 1990; Fernandez-Moreno et al., 1991; Raibaud et al., 1991; Stutzman-Engwall et al., 1992; Geistlich et al., 1992) . However, little is understood of the regulatory mechanisms that are involved in the expression of the activator genes.
In Streptomyces coeticolor A3(2), the most fully genetically characterized streptomycete, potential pleiotropic regulatory genes have been identified that are required for, or influence, the production of all four of the antibiotics (actinorhodin, undecylprodigiosin, methylenomycin, and a calcium-dependent antibiotic ; Hopwood, 1988) known to be made by this strain. These genes fall into two classes: those that affect only antibiotic production (absA and absB , afsB (Horinouchi et al., 1983; Horinouchi et al., 1989) , afsR (Horinouchi et al., 1990) and abaA (Fernandez-Moreno et al., 1992) ), and those that affect both antibiotic production and morphological differentiation (bldA-D and bldG-H; Hopwood, 1988; Champness, 1988; Chater, 1989) . The existence of these bId mutants suggests that morphological differentiation and antibiotic production share some elements of genetic control. Of particular note is bldA; this gene encodes a tRNALUeuUA that is apparently the only tRNA species in S. coeticolor A3 (2) that can efficiently translate the rare leucine codon UUA (Leskiw et al., 1991 b) . Moreover, the majority (12/15) of UUA codons so far identified in streptomycetes are found in genes connected with antibiotic production or morphological differentiation that are expected to be expressed late in growth (Leskiw et al., 1991 a) . In particular, actII-ORF4, the pathway-specific activator gene for actinorhodin biosynthesis, encodes an mRNA that contains a single UUA codon whose replacement by UUG led to a loss of bldA-dependence of actinorhodin production, Fig. 1 . A. Growth curve of S. coelicolor A3(2) strain M145 in casamino-acid-supplemented medium; to, doubling time (h); the shaded box labelled ACT indicates the presence of actinorhodin in the culture. B, C and D. S1 nuclease mapping of actII-ORF4 (B), actIII (C), and actVI-ORF1 (D) transcripts in RNA samples obtained from the culture shown in (A) at the times indicated; EXP and STAT, exponential and stationary phases of growth, respectively; the shaded area between them indicates the transition phase; SM, end-labelled HpaII-digested pBR322 size marker; Probe, the location of full-length probe. The lower band present in (D) may represent a second transcriptional start site for actVI-ORF1, RNA processing or degradation, or an artefact of the S1 nuclease mapping procedure.
prompting suggestions that this codon was the direct target for translational control of actinorhodin production by bldA (Fernandez-Moreno et al., 1991) .
Here, we assess the temporal and growth-phasedependent expression of actII-ORF4, the actinorhodin biosynthetic structural genes actIII (Hallam et al., 1988) and actVI-ORF1 (F. Malpartida, personal communication) , and bldA, and provide evidence to suggest that bldA is not involved, under the conditions used, in the temporal regulation of actinorhodin production, which appears to occur at the transcriptional level.
Results

Actinorhodin gene expression is growth-phasedependent
S. coelicolor A3(2) strain M145 grew in casamino-acidsupplemented minimal medium with a doubling time of 2.1 h and began the transition into stationary phase approximately 15 h after inoculation, whereupon actinorhodin appeared in the mycelium (Fig. 1A) . S1 nuclease protection experiments with RNA from exponential and stationary phase cultures revealed actII-ORF4 transcripts at a low level in exponential phase; their amount increased greatly at the end of exponential growth ( Fig. 1B) , with the highest levels occurring during the transition phase (the increase in the level of fully protected probe, which follows the increase in the level of the actII-ORF4 transcript, was not always observed, but may reflect transcriptional readthrough from actII-ORF3 (Fernlndez-Moreno et al., 1991 ) ). Transcripts for actIII and actVI-ORF1 were detected 13.3 hand 14.3 h after inoculation, respectively (Fig. 1, C and D) , and increased in abundance as the culture entered stationary phase, following closely the increase in the level of actII-ORF4
mRNA.
The effect of extra copies of actII-ORF4 on the temporal expression of actIII and on actinorhodin production was assessed in M145 containing multicopy plasmid p1J68. actII-ORF4 transcripts were readily detected in early exponential cultures and their level increased markedly in mid-exponential phase and then remained constant ( Fig. 2A) . A similar, but slightly delayed profile, was observed for the actIII transcripts ( Fig. 2B ) (a faint band was also observed in the earliest sample (OD450nm = 0.28) after prolonged exposure). Actinorhodin production was first detected spectrophotometrically during mid to late exponential growth; the concentration in stationary-phase cultures was approximately 10 times that observed with M145.
Transcription of bid A occurs throughout growth in liquid culture S1 nuclease protection experiments were performed with RNA from exponential-and stationary-phase cultures to assess the temporal pattern of bldA transcription (Fig. 3 ).
The smallest protected fragment (approximately 80 nucleotides (nt) represents the 5' end of the mature tRNAULeuUA ; the other two bands were observed also either in in vitro transcription studies (the band of approximately 150 nt; (Lawlor, 1987) or sometimes in primer extension experiments (the band of approximately 100 nt; B. K. Leskiw, personal communication) , and both may represent in vivo transcriptional start sites. Whereas the levels of the larger protected fragments declined with culture age (after an initial increase in the c. 100 nt fragment), the fragment representing the 5' end of the mature tRNAULeuUA increased slightly during early exponential growth and then remained relatively constant. An essentially identical profile of bldA transcripts was observed using a richer medium (YEME; Hopwood et al., 1985) and spores of S. coelicolor A3(2) M145 that had not been germinated prior to inoculation, suggesting that the profiles are typical of cultures grown in liquid medium.
To confirm that the signals observed represented bldA, and not cross-hybridization to related tRNA species, S 1 nuclease protection experiments were carried out on RNA isolated from early and late exponential phase, and stationary-phase cultures of S. coelicolor A3(2) strains J1501 (bldA+) and J1681 (ΔbldA); prolonged exposure revealed a faint signal with RNA from J1681, but a very strong one with RNA from J1501 ( Fig. 3 ; only the results obtained with the stationary-phase cultures are shown), indicating that almost all of the signal observed in M145 represented bldA transcripts.
Translation of UUA codons in an actII-ORF4::ermE fusion transcript occurs throughout growth in liquid culture
The presence of bldA transcripts throughout growth did not necessarily reflect the presence of a functional bldA tRNAULeuUA; perhaps the lack of 3' processing, charging by the appropriate amino acyl tRNA synthetase, or some . S1 nuclease mapping of bldA transcripts in RNA samples prepared from S. coelicolor A3(2) strains M145, J1501 and J1681 (ΔbldA). tRNA, protected fragment corresponding to the 5' end of the mature bldA tRNA; S1 PE and S1 IVT, S1-nuclease-resistant fragments corresponding to the 5' end of transcripts observed previously in primer extension experiments or in in vitr o transcription studies, respectively. See the legend to Fig. 1 for other abbreviations.
other modification, prevented translation of UUA codons during exponential growth. To address this point, translational fusions were made between the 5' region of actII-ORF4, including the actII-ORF4 promoter and the unique UUA codon, and the ermE gene of Saccharopolyspora erythrea. ermE, which confers resistance to macrolide, lincosamide and streptogramin B-type antibiotics, encodes a 23S rRNA methylase (Uchiyama and Weisblum, 1985; Dhillon and Leadlay, 1990) for which polyclonal antibodies had been raised using oligopeptides as antigens. pIJ2250 contained the first five codons of actII-ORF4, with the fifth being the unique UUA codon; pIJ2251 differed in that the UUA codon had been changed to the synonymous leucine codon UUG, and pIJ2252 differed from pIJ2250 in containing additional UUA codons at positions six and seven ( Fig. 4 ). Protein and RNA samples were prepared from cultures containing the three plasm ids during exponential growth and during the transition into stationary phase, and analysed by Western blotting and S1 nuclease mapping. The ermE methylase (with a predicted size of 43 kDa (EMBL nucleotide database accession number X51891), but which migrates on SDS-polyacrylamide gels against prestained markers with an apparent size of 45 kDa; M. J. Bibb, unpublished) was readily detected in extracts from a control culture, M145(pIJ427) (a pIJ486 derivative that contains the native ermE), but not in extracts from M145(pIJ486) (a negative control). The three constructions containing the translational fusions were expected to give a novel protein of 44.3 kDa; all three yielded a fusion protein larger than the native methylase. Moreover, the fusion protein was readily detected in early exponential growth and increased in amount as the culture entered the transition phase. While the amounts of fusion protein detected in extracts of M145 containing pIJ2250 or pIJ2251 were very similar, the level obtained from pIJ2252 was higher. To assess whether this difference, and the temporal increase in the level of the fusion proteins, reflected an increase in translational efficiency or an increase in the amount of transcript, RNA from culture samples corresponding in time to those used for protein extraction were monitored by S1 nuclease mapping ( Fig. 5B ). The fusion protein:fusion transcript ratio increased during growth approximately twofold for all three cultures. The level of fusion mRNA observed with p1J2252, which contains three UUA codons, was notably higher than with the other two constructions (Fig. 5B ).
Translation of actII-ORF4::ermE fusion transcripts containing UUA codons is bldA-dependent
The presence of actII-ORF4 on a multicopy plasmid restores actinorhodin production to bldA mutants (Passantino et al., 1991) , presumably by a low level of mistranslation of the unique UUA codon by another tRNA via an imperfectly matched codon-anticodon interaction;
increased levels of actII-ORF4 transcripts from the multicopy vector presumably allow for the synthesis of enough Shaded triplets indicate the actII-ORF4 UUA codon in pIJ2250, and changes from the sequence present in the latter in pIJ2251 and p1J2252. The ATG triplet corresponding to the translational start codon of actII-ORF4 and of the fusion transcripts is underlined; the GTG corresponding to the translational start codon of er mE is in italics and the BamHI site used for cloning is in bold letters. B. S1 nuclease mapping of actII-ORF4::ermEtranscripts in RNA samples from the same cultures used in A. The asterisk indicates the protected fragment that results from cleavage by S1 nuclease at the region of mismatch between the probe (obtained by PCR using pIJ2250 as a template) and the fusion transcripts. The faint bands present at a similar position in the pIJ2250 and pIJ2251 tracks do not comigrate with this protected fragment upon prolonged electrophoresis and are present in all lanes; they may reflect an artefact of the S1 nuclease mapping procedure. See the legend to Fig. 1 for other abbreviations.
activator to elicit expression of the act structural genes. The same explanation might have applied to the results obtained with the actII-ORF4::ermE fusions, since they are also present on a high-copy-number plasmid. To assess whether the fusion protein detected by Western blotting in young cultures resulted from translation of the UUA codons by tRNAULeuUA, and not by mis-translation, the three plasmids were introduced into the S. coelicolor A3(2) bldA mutant J1700, and the amount of fusion protein and fusion mRNA in exponential cultures was analysed. The fusion protein was detected only in extracts prepared from J1700(pIJ2251) (Fig. 6A ), although the levels of fusion transcript detected in J1700(p1J2250) and J1700(p1J2251) were very similar (Fig. 6B ). As noted for M145, the level of fusion mRNA with pIJ2252 was higher than with the other two constructions (Fig. 6B ).
Discussion
Transcription of the activator gene actII-ORF4 is clearly growth-phase-dependent in liquid medium, reaching a maximum during the transition from exponential to stationary phase. Transcription of actIII and actVI-ORF1
occurs after the accumulation of almost maximal levels of the actII-ORF4 transcript, suggesting that a threshold concentration of the activator is needed for transcription of the biosynthetic structural genes, a possibility noted by Hopwood et al. (1986) . The presence of multiple copies of actII-ORF4 leads to high levels of the actII-ORF4 transcript; probably as a consequence, expression of actIII is enhanced and actinorhodin appears in early to mid-exponential growth, suggesting that the only limitation on actinorhodin production in rapidly growing cultures, under the The pleiotropic effect of bldA mutations on antibiotic production, the unusual distribution of UUA codons and data suggesting that bldA, in surface-grown cultures, was transcribed only later in growth , led to the proposal that bldA represented a novel mechanism of translational control of antibiotic production (Chater, 1990; Leskiw et al., 1991 b) . This was consistent with data indicating that the transcription of undecylprodigiosin (Guthrie and Chater, 1990) , actinorhodin (Bruton et al., 1991; Fernandez-Moreno et al., 1991) subjected to a mutational bias that has led to a high genomic G+C content (on average, 74 mol%; Gladek and Zakrzewska, 1984) and consequently to a high degree of synonymous codon preference in which G+C-rich codons predominate (Wright and Bibb, 1992) . In addition to mutational bias, there is evidence for translational selection in
Streptomyces (Wright and Bibb, 1992) ; if UUA codons were inefficiently translated, they might have been selectively removed from genes expressed at high and moderate levels, but retained in those expressed at low levels.
Regulatory genes, like actII-ORF4, are generally expected to be expressed at low levels. The occurrence of UUA codons in such genes, and not in the primary metabolic and antibiotic biosynthetic structural genes sequenced so far, may reflect the operation of translational selection in the latter, rather than a novel mechanism of translational control. However, the levels of fusion proteins observed in these studies (Fig. 5 ) would suggest that UUA is translated at least as efficiently as UUG. Furthermore, the correspondence between the amount of fusion transcript and protein observed with M145/p1J2251 and M145/p1J2252 suggests that the presence of UUA codons is not a rate-limiting factor during translation.
Thus, in the absence of a confirmed regulatory role for bldA, a satisfactory explanation for the unusual occurrence of UUA codons remains elusive.
From these studies we conclude that the growh-phase-dependent regulation of actinorhodin biosynthesis, under the conditions used, occurs through the transcriptional control of the activator gene actII-ORF4. Similar results have been obtained for the regulation of undecylprodigiosin in the same strain (Takano et al., 1992) , where the expression of the pathway-specific activator gene, redO, is also transcriptionally regulated, and shows a strong growth-phase dependence. How the transcriptional control of activator genes such as redO and actII-ORF4 occurs must now be addressed, and it is reasonable to assume that at least some of the previously recognized pleiotropic genes playa direct role in their activation.
Experimental procedures
Bacterial strains and plasm ids Escherichia coli strains were JM101 (Sambrook et al., 1989) and ET12567 hsdM, hsdR, recF143, galK2, ga1T22, lacY1, leuB6, tonA31, rpsL136, hisG4, glnV44;  a gift from Tanya MacNeil). S. coelicolor A3(2) strains were M145 (SCP1-, SCP2-, prototrophic; Hopwood et al., 1985) , J1501 (hisA1, uraA1, strA1, pgl, SCP1-, SCP2-; Hopwood et al., 1985) , and its derivatives, J1700 (bldA39; Leskiw et al., 1991b; Lawlor et al., 1987) ) was used as a source of ermE for the construction of the translational fusions, and pIJ5104 (Hallam et al., 1988) and pIJ2334 (a pBR329 derivative carrying act DNA between sites 10 and 13 of the restriction map of Malpartida and Hopwood (1986) ) were used as sources of probes for S1 nuclease mapping of actIII and actII-ORF4, respectively. Streptomyces plasmids pIJ2303 ) and pIJ580 (Lawlor, 1987) were used as templates for the polymerase chain reaction (PCR) amplification (Erlich, 1989) of parts of actVI-ORF1 and bldA, respectively; pIJ68 (Passantino et al., 1991) is a derivative of the multicopy vector pIJ699 (Kieser and Melton, 1988) containing actII-ORF4, pIJ486 (Ward et al., 1986) was used as vector for the actII-ORF4::ermE fusions, and pIJ427 is pIJ486 containing ermE as a 1.7 kb KpnI fragment , with ermE transcribed in the same direction as the neo gene of the vector.
Culture conditions and microbiological procedures
Liquid cultures of S. coelicolor A3(2) were grown in a minimal medium supplemented with 0.2% w/v casamino acids (Takano et al., 1992) , and actinorhodin was detected as described by Strauch et al. (1991) ; protoplast production and transformation were as in Hopwood et al. (1985) . E. coli strains were grown and transformed by standard procedures (Sambrook et al., 1989) .
Manipulation of DNA, RNA and cloning procedures
Standard procedures were used for S. coelicolor A3(2) (Hopwood et al., 1985) and for E. coli (Sambrook et al., 1989) .
Construction of the actII-ORF4::ermE translational fusions
The PCR was used for mutagenesis of the sequence containing the actII-ORF4 promoter and 5' coding region. The 5 oligonucleotide was 5'-AAGCTTGGATCCTCGCTGCACT-GATTAATT-3' with a BamHI site located at positions 7-12. The sequences of the 3' oligonucleotides were complementary to those shown in Fig. 4 ; all contained a BamHI site that allowed the PCR products to be cloned into BamHI-cleaved pIJ452 such that the N-terminal coding region of actII-ORF4 was in frame with the full-length ermE gene present in the vector. JM101 transform ants were selected on Luria-Bertani (LB) plates containing ampicillin (100 µg ml-1) and then replicaplated onto LB plates containing ampicillin (100 µg ml-1) and lincomycin (300µg ml-1) to obtain those with the actII-ORF4 segment in the correct orientation (previous work had indicated that protein fusions could be made to the N-terminus of the methylase that resulted in an enzyme that could still confer resistance to lincomycin; M. J. Bibb, unpublished) . XbaI-SstI fragments containing the actII-ORF4::ermE fusions were gelpurified and cloned into the Streptomyces multicopy vector pIJ486 cleaved with the same enzymes; S. coelicolor M145 transformants were selected onthiostrepton (200µg ml-1) and then replica-plated to lincomycin (500 µg ml-1). The predicted sequences of the final constructions were confirmed using the dideoxy-chain termination method (Sanger et al., 1977) adapted for use with plasmid DNA (G. Murphy, personal communication) and the modified T7 DNA polymerase (Sequenase, USB) using oligonucletide primers synthesized on a Pharmacia Gene Assembler.
S1 nuclease mapping
For each S1 nuclease reaction, 10-30 µg of RNA were hybridized in NaTCA buffer (Murray, 1986) to about 0.02 pmol (approximately 10 4 Cerenkov counts min-1 ) of the following probes. For actII-ORF4 (Fernandez-Moreno et al., 1991) , a 465 bp XhoI-AseI fragment containing the actII-ORF4 promoter region uniquely labelled at the 5' end of the XhoI site within the actII-ORF4 coding region was used. For actIII (Hallam et al., 1988) , a 360 bp SalI-BamHI fragment was used that contained the actIII promoter region uniquely labelled at the 5 end of the Sail site within the actIII coding region. For bldA, the 5' end of the synthetic oligonucleotide 5'-CGGAGCCG-GACTTGAACC-3', corresponding to a region close to the end of the bldA gene , was labelled with [32p]_ ATP using T4 polynucleotide kinase, and then used in the PCR with the unlabelled 5' oligonucleotide 5'-CATGGATCCACC-CGGTAACTGATGCACC-3' that corresponds to the region upstream of the bldA promoter to generate a 206 bp probe. For acNI-ORF1 (F. Malpartida, personal communication), the 5'labelled 3' oligonucleotide 5'-ACGTCCGGCTCGTACTC-GATG-3' and the unlabelled 5' oligonucleotide 5'-CTTGCG-GTGGAAGTCCTCCAG-3' (whose sequence lies an undetermined distance upstream of the actVI-ORF1 promoter) were used in a similar fashion to generate a 471 bp probe. For the actII-ORF4::ermE transcripts, the 5' end of the labelled oligonucleotide 5'-GAGTTCCCTGGTGAGCAGCCCTTC-3' (corresponding to a region approximately 250 bp downstream of the ermE GTG start codon; Bibb et al., 1985) , was used in the PCR with the unlabelled oligonucleotide 5'-AAGCT-TGGATCCTCGCTGCACTGATTATT-3' (corresponding to sequences upstream of the actII-ORF4 promoter) and pIJ2250 template DNA to generate a 403 bp probe. All subsequent steps were as described by Strauch et al. (1991) . For quantitative estimates of the relative amounts of the RNA-protected fragments, X-ray films were preflashed, exposed at -70DC (Laskey, 1980) and scanned on a Joyce-Loebl Chromoscan 3 scanning densitometer. Increasing the amount of RNA in stepwise fashion from 5 µg to 50 µg led to a proportional increase in the level of protected fragment, indicating conditions of probe excess for all of the S1 mapping experiments reported.
Protein extraction and Western blotting
Cell extracts were prepared as previously described (Gramajo et al., 1991) and protein concentrations were determined by the method of Bradford (1976) ; fractions were analysed by SDS-PAGE (Laemmli, 1970) and by Western blotting (Burnette, 1991) . Antibodies against the N-terminus of the ermE methylase were raised in rabbits using the synthetic oligopeptide MSSSDEQPRPRRR . The antibodies were used at 1:4000 dilution with a goat anti-rabbit IgG-alkaline phosphatase conjugate (Bethesda Research Laboratories) as second antibody. Relative amounts of fusion protein were determined by scanning negatives of developed blots on a Joyce-Loebl Chromoscan 3 scanning densitometer; varying the amount of cell extract loaded onto the gel confirmed that the amounts of fusion protein quantified fell within the linear range of the negative and densitometer.
